Clinical implication of PD-L2 in the prognosis assessment of HNSCC immunotherapy

Clinical implication of PD-L2 in the prognosis assessment of HNSCC immunotherapy

Background and purpose: Programmed death-1 (PD-1) monoclonal antibody therapy plays an increasingly important role in the treatment of head and neck squamous cell carcinoma (HNSCC). However, low response rate and lack of predictive biomarkers are still the challenging problems. This study aimed to c...

Full description

Bibliographic Details
Main Author: HUANG He, JU Houyu, YANG Wenyi, YAN Ming, REN Guoxin, HU Jingzhou
Format: Article
Language:English
Published: Editorial Office of China Oncology 2023-06-01
Series:Zhongguo aizheng zazhi
Subjects:
|head and neck squamous cell carcinoma|immunotherapy|programmed death ligand-2
Online Access:http://www.china-oncology.com/fileup/1007-3639/PDF/1690339627273-1495212812.pdf

Similar Items

Similar Items